MedPath

Verification test on improvement in a liver disorder marker and a cholesterol lowering effect

Phase 2
Conditions
Healthy subjects
Registration Number
JPRN-UMIN000028838
Lead Sponsor
HUMA R&D CORP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
69
Inclusion Criteria

Not provided

Exclusion Criteria

1. Currently in treatment with medication or seeing a doctor for treatment 2. Previous history of severe liver disorder (viral hepatitis, drug-induced liver injury, cirrhosis) or currently suspected to have liver disorder (a positive test result on hepatitis screening, etc.) 3. Previous history of liver disorder or severe disorder related to kidney, endocrine, cardiovascular system, gastrointestine, lung, blood, metabolism, or currently presence of complications 4. Previous history of a drug allergy and/or food allergy 5. Regular intake of a health food product or supplement possibly influencing the liver function and lowering cholesterol 6. Regular intake of medication possibly influencing the liver function and lowering cholesterol 7.Extreme faddiness 8. Extremely irregular lifestyle such as a dietary pattern and a sleeping pattern 9.Presence or previous history of mental disorder (depression, etc.) 10. A large volume of alcohol intake (average pure alcohol intake per day for males: 60 g or over, females: 40 g or over) 11.11) Current participation in another clinical trial or participation in another clinical trial within the last three months 12.Determined by the investigator to be unsuitable for enrollment in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.ALT 2.LDL-C
Secondary Outcome Measures
NameTimeMethod
1.GAMMA-GTP 2.AST 3.TC 4.HDL-C 5.TG
© Copyright 2025. All Rights Reserved by MedPath